David A. Phoenix

5.5k total citations
154 papers, 4.3k citations indexed

About

David A. Phoenix is a scholar working on Molecular Biology, Microbiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David A. Phoenix has authored 154 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Molecular Biology, 51 papers in Microbiology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David A. Phoenix's work include Antimicrobial Peptides and Activities (51 papers), Lipid Membrane Structure and Behavior (43 papers) and RNA and protein synthesis mechanisms (27 papers). David A. Phoenix is often cited by papers focused on Antimicrobial Peptides and Activities (51 papers), Lipid Membrane Structure and Behavior (43 papers) and RNA and protein synthesis mechanisms (27 papers). David A. Phoenix collaborates with scholars based in United Kingdom, Germany and United States. David A. Phoenix's co-authors include Frederick Harris, Sarah R. Dennison, Mark Wainwright, Jaipaul Singh, D.R.A. Wareing, Manuela Mura, James C. Wallace, Lee Chatfield, Waqar Ahmed and Abdelbary Elhissi and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemistry.

In The Last Decade

David A. Phoenix

153 papers receiving 4.2k citations

Peers

Countries citing papers authored by David A. Phoenix

Since Specialization

Citations

This map shows the geographic impact of David A. Phoenix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Phoenix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Phoenix more than expected).

Fields of papers citing papers by David A. Phoenix

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Phoenix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Phoenix. The network helps show where David A. Phoenix may publish in the future.

Co-authorship network of co-authors of David A. Phoenix

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Phoenix. A scholar is included among the top collaborators of David A. Phoenix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Phoenix. David A. Phoenix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bacterial susceptibility and resistance to modelin-5 2023 ·Soft Matter ·Sarah R. Dennison, (unknown), (unknown), Frederick Harris, David A. Phoenix	2
2	Temporin B Forms Hetero-Oligomers with Temporin L, Modifies Its Membrane Activity, and Increases the Cooperativity of Its Antibacterial Pharmacodynamic Profile 2022 ·Biochemistry ·(unknown), (unknown), Giorgia Manzo, Charlotte K. Hind, Melanie Clifford, J. Mark Sutton, Christian D. Lorenz, David A. Phoenix, A. James Mason	7
3	Impacts of Metabolism and Organic Acids on Cell Wall Composition and Pseudomonas aeruginosa Susceptibility to Membrane Active Antimicrobials 2021 ·ACS Infectious Diseases ·Giorgia Manzo, (unknown), Charlotte K. Hind, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Roland A. Fleck, J. Mark Sutton, David A. Phoenix, A. James Mason	8
4	Minor sequence modifications in temporin B cause drastic changes in antibacterial potency and selectivity by fundamentally altering membrane activity 2019 ·Scientific Reports ·Giorgia Manzo, (unknown), (unknown), Charlotte K. Hind, Melanie Clifford, Tam T. T. Bui, Alex F. Drake, Roger Atkinson, J. Mark Sutton, Giovanna Batoni, Christian D. Lorenz, David A. Phoenix, A. James Mason	25
5	Temporin L and aurein 2.5 have identical conformations but subtly distinct membrane and antibacterial activities 2019 ·Scientific Reports ·Giorgia Manzo, (unknown), Charlotte K. Hind, Melanie Clifford, (unknown), (unknown), Sukhvinder S. Bansal, Tam T. T. Bui, Alex F. Drake, Roger Atkinson, J. Mark Sutton, Christian D. Lorenz, David A. Phoenix, A. James Mason	30
6	Dental tools, Human tooth and environment 2014 ·CLOK (University of Central Lancashire) ·Waqar Ahmed, Mark Jackson, Htet Sein, C.A. Rego, (unknown), David A. Phoenix, St John Crean	3
7	Diamond deposition of tungstencarbide bursing VFCVD 2014 ·CLOK (University of Central Lancashire) ·Waqar Ahmed, Mark J. Jackson, Htet Sein, (unknown), A. Elhissi, David A. Phoenix, StJohn Crean	2
8	Diamonds synthesis, properties and applications 2014 ·CLOK (University of Central Lancashire) ·Waqar Ahmed, Mark J. Jackson, Htet Sein, (unknown), A. Elhissi, David A. Phoenix, StJohn Crean	2
9	The cooperative behaviour of antimicrobial peptides in model membranes 2014 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Jianping Wang, Manuela Mura, Yuhua Zhou, Marco Pinna, A. V. Zvelindovsky, Sarah R. Dennison, David A. Phoenix	19
10	The interaction of aurein 2.5 with fungal membranes 2014 ·European Biophysics Journal ·Sarah R. Dennison, (unknown), Frederick Harris, David A. Phoenix	6
11	Aurein 2.3 functionality is supported by oblique orientated α-helical formation 2012 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Manuela Mura, Sarah R. Dennison, A. V. Zvelindovsky, David A. Phoenix	20
12	A Study on the Importance of Phenylalanine for Aurein Functionality 2009 ·Protein and Peptide Letters ·Sarah R. Dennison, Frederick Harris, David A. Phoenix	14
13	Evidence of rare codon clusters within Escherichia coli coding regions 2006 ·FEMS Microbiology Letters ·David A. Phoenix, Eugene Korotkov	11
14	Phenothiazinium Based Photosensitisers - Photodynamic Agents with a Multiplicity of Cellular Targets and Clinical Applications 2005 ·Current Drug Targets ·Frederick Harris, Lee Chatfield, David A. Phoenix	108
15	Calpains: targets of cataract prevention? 2004 ·Trends in Molecular Medicine ·(unknown), Frederick Harris, Sarah R. Dennison, Jaipaul Singh, David A. Phoenix	64
16	Beneficial effect and mechanism of action of Momordica charantia in the treatment of diabetes mellitus: a mini review 2003 ·Celia Garau, Elizabeth Cummings, David A. Phoenix, Jaipaul Singh	30
17	A Study on the C-Terminal Membrane Anchoring of Escherichia coli Penicillin-Binding Protein 5 2002 ·Biochemical and Biophysical Research Communications ·Klaus Brandenburg, Frederick Harris, David A. Phoenix, Ulrich Seydel	1
18	Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains ofStaphylococcus aureus 1998 ·FEMS Microbiology Letters ·Mark Wainwright, David A. Phoenix, (unknown), D.R.A. Wareing, (unknown)	183
19	An investigation into the ability of C-terminal homologues of Escherichia coli low molecular mass penicillin-binding proteins 4, 5 and 6 to undergo membrane interaction 1997 ·Biochimie ·Frederick Harris, David A. Phoenix	12
20	Monte Carlo analysis of potential C-terminal membrane interactive alpha-helices 1996 ·Protein and Peptide Letters ·Arthur Pewsey, David A. Phoenix, (unknown)	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact